KINIKSA PHARMACEUTICALS
Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with a significant unmet medical need. It has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. It has three clinical-stage product candidates, one of which is anticipated to commence a Phase 3 clinical tr... ial in 2018. They follow a disciplined and methodical approach to selectively identify and acquire product candidates with strong biologic rationales or validated mechanisms of action. The company's portfolio of product candidates offers multiple development opportunities. By modulating different parts of the innate and adaptive immune system, these product candidates together have the potential to provide a variety of mechanisms to address multiple devastating diseases.
KINIKSA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Hamilton, Hamilton, Bermuda
Country:
Bermuda
Website Url:
http://www.kiniksa.com
Total Employee:
11+
Status:
Active
Contact:
(781) 431-9100
Email Addresses:
[email protected]
Total Funding:
400 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Content Delivery Network Domain Not Resolving Nginx Euro Microsoft Exchange Online
Similar Organizations
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
AxisPharm
AxisPharm specializes in ADC drug development, bioconjugation, mass spectrometry, and structure elucidation.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity
Fidelity investment in Series C - Kiniksa Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Kiniksa Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series C - Kiniksa Pharmaceuticals
Deerfield
Deerfield investment in Series C - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series C - Kiniksa Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - Kiniksa Pharmaceuticals
ArrowMark Partners
ArrowMark Partners investment in Series C - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series A - Kiniksa Pharmaceuticals
Official Site Inspections
http://www.kiniksa.com
- Host name: 151.101.1.193
- IP address: 151.101.1.193
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kiniksa Pharmaceuticals"
About Us | Kiniksa Pharmaceuticals
Founded in 2015, Kiniksa Pharmaceuticals is a global biopharmaceutical company dedicated to advancing novel, transformative therapies for patients with unmet medical needs, with a focus …See details»
Our Leaders | Kiniksa Pharmaceuticals
Learn about leadership at Kiniksa Pharmaceuticals, including our management team and board of directors.See details»
Kiniksa Pharmaceuticals - Crunchbase Company Profile & Funding
Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from …See details»
Kiniksa Pharmaceuticals - LinkedIn
Kiniksa offers competitive benefits and dynamic career opportunities across our organization. We foster a culture of passion, innovation, and rapid execution to help fulfill our mission.See details»
Investors & Media | Kiniksa Pharmaceuticals
Feb 25, 2025 The Investor Relations website contains information about Kiniksa Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»
Kiniksa Pharmaceuticals Management Team | Org Chart
Kiniksa Pharmaceuticals employs 311 employees. The Kiniksa Pharmaceuticals management team includes Tom Koenig (Vice President, US and Global Value and Access), Chad Morin …See details»
Kiniksa Pharmaceuticals Provides Corporate Update
Apr 1, 2024 About Kiniksa Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients …See details»
Kiniksa Pharmaceuticals Information - RocketReach
Kiniksa Pharmaceuticals is a Biotechnology Research, Pharmaceuticals, and Biopharma company located in Lexington, Massachusetts with $70.7 million in revenue and 326 …See details»
Kiniksa Pharmaceuticals Overview | SignalHire Company Profile
To connect with Kiniksa Pharmaceuticals employee register on SignalHire. Organization Website kiniksa.com Social Links Contact Email [email protected] Phone Number 781-431-9100 Kiniksa …See details»
Kiniksa Pharmaceuticals - Funding, Financials, Valuation & Investors
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.See details»
Kiniksa Pharmaceuticals - Craft
Oct 29, 2024 Kiniksa Pharmaceuticals has 4 employees across 4 locations and $270.26 m in annual revenue in FY 2023. See insights on Kiniksa Pharmaceuticals including office …See details»
Kiniksa Pharmaceuticals Provides Corporate and Portfolio Update
Jan 9, 2023 Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating …See details»
Press Releases - Kiniksa Pharmaceuticals
Oct 29, 2024 The Investor Relations website contains information about Kiniksa Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»
Kiniksa Pharmaceuticals Mission, Benefits, and Work Culture - Indeed
Come see what’s going on inside Kiniksa Pharmaceuticals, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make …See details»
Grants and Giving | Kiniksa Pharmaceuticals
Kiniksa is committed to improving healthcare and discovering treatments for the patients who need it most. We provide grants, sponsorships, and programs to help advance the …See details»
Kiniksa Pharmaceuticals - Contacts, Employees, Board Members, …
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.See details»
Kiniksa Pharmaceuticals Announces Global License Agreement …
Aug 3, 2022 – Kiniksa to receive $100 million in upfront and near-term payments – – Kiniksa is eligible to receive development and commercial milestones as well as royalties on net sales – …See details»
Working at Kiniksa Pharmaceuticals: 4 Reviews - Indeed
Reviews from Kiniksa Pharmaceuticals employees about Kiniksa Pharmaceuticals culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Our Medicines & Pipeline | Kiniksa Pharmaceuticals
Discover our portfolio of FDA-approved therapeutic medicines and pipeline of immune-modulating, clinical-stage product candidates.See details»
Kiniksa Pharmaceuticals Announces Development of KPL-387 in …
Feb 25, 2025 Kiniksa continues to focus development on diseases with unmet need, prioritizing cardiovascular indications. Kiniksa is developing KPL-387, a fully human immunoglobulin G2 …See details»